Published in Acta Med Scand on October 01, 1971
Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J Clin Invest (1977) 1.12
Sex steroid influence on triglyceride metabolism. J Clin Invest (1975) 1.03
Nucleo-cytoplasmic relationships of oestrogen receptors in rat liver during the oestrous cycle and in response to administered natural and synthetic oestrogen. Biochem J (1980) 0.92
Gonadal hormones and triglycerides. Proc R Soc Med (1974) 0.88
Secondary hyperlipidaemia. J Clin Pathol Suppl (Assoc Clin Pathol) (1973) 0.75
Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina. West J Med (1975) 0.75
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev (2005) 5.72
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet (1972) 4.54
The prostaglandins: a family of biologically active lipids. Pharmacol Rev (1968) 3.85
Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet (2001) 3.60
Flaws in methods of evidence-based medicine may adversely affect public health directives. Surgery (2005) 3.49
The predictive validity of body mass index based on self-reported weight and height. Int J Obes (1989) 2.65
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32
Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr (1997) 2.27
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation (1999) 2.27
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) (2011) 2.08
Quality of alternative medicine--complications and avoidable deaths. Qual Assur Health Care (1990) 2.00
Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states. Atherosclerosis (1978) 1.83
Weight development over time in parous women--the SPAWN study--15 years follow-up. Int J Obes Relat Metab Disord (2003) 1.78
Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia (1994) 1.73
Maternal body weight development after pregnancy. Int J Obes (1990) 1.72
Night eating and nocturnal eating-two different or similar syndromes among obese patients? Int J Obes Relat Metab Disord (2001) 1.63
Concentration of triglycerides, phospholipids and glycogen in skeletal muscle and of free fatty acids and beta-hydroxybutyric acid in blood in man in response to exercise. Eur J Clin Invest (1971) 1.62
Weight maintenance after a very low calorie diet (VLCD) weight reduction period and the effects of VLCD supplementation. A prospective, randomized, comparative, controlled long-term trial. J Intern Med (1995) 1.58
Long-term effects of a very low calorie diet (Nutrilett) in obesity treatment. A prospective, randomized, comparison between VLCD and a hypocaloric diet+behavior modification and their combination. Int J Obes Relat Metab Disord (1997) 1.58
An appraisal of the clinical effect of three different oral contraceptive agents and their influence on transaminase activity. Acta Obstet Gynecol Scand (1966) 1.56
Trends in eating patterns, physical activity and socio-demographic factors in relation to postpartum body weight development. Br J Nutr (1994) 1.54
Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev (2000) 1.53
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients. Br J Clin Pharmacol (1984) 1.53
Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Prostaglandin and related factors 35. Acta Physiol Scand (1965) 1.52
Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand (1979) 1.44
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord (1999) 1.41
Hyper- -lipoproteinemia in men exposed to chlorinated hydrocarbon pesticides. Acta Med Scand (1972) 1.40
Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic men. J Cardiovasc Risk (1997) 1.40
Obesity treatment and attrition: no relationship to obesity level. Obes Res (1996) 1.39
Comparison between the use of isopropanol and tetramethylurea for the solubilisation and quantitation of human serum very low density apolipoproteins. Anal Biochem (1978) 1.38
Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease. Atherosclerosis (1980) 1.36
Long-term weight development after pregnancy. Obes Rev (2002) 1.35
High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb (1991) 1.34
Application of a new intravenous fat tolerance test in the study of hypertriglyceridaemia in man. J Atheroscler Res (1969) 1.34
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr (1998) 1.32
Prevalence of obesity in Sweden. Obes Rev (2006) 1.28
An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod (1997) 1.28
Inhibition of the mobilization of free fatty acids from adipose tissue. Physiological aspects on the mechanisms for the inhibition of mobilization of FFA from adipose tissue. Ann N Y Acad Sci (1965) 1.23
Is walking for exercise too exhausting for obese women? Int J Obes Relat Metab Disord (1997) 1.23
Headache and treatment with oral contraceptives. Acta Neurol Scand (1970) 1.23
Factors related to body weight changes during and after pregnancy: the Stockholm Pregnancy and Weight Development Study. Obes Res (1996) 1.21
Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol (2000) 1.21
Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines. Int J Obes Relat Metab Disord (2003) 1.20
Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia. Lancet (1979) 1.19
Circulatory and respiratory effects of different doses of prostaglandin E1 in man. Acta Physiol Scand (1969) 1.18
Intravenous prostaglandin E1 in severe peripheral vascular disease. Lancet (1976) 1.17
Clinical, hemodynamic and metabolic effects of intraarterial infusions of prostaglandin E1 in patients with peripheral vascular disease. Adv Prostaglandin Thromboxane Res (1976) 1.17
The Christmas factor in obesity therapy. Int J Obes Relat Metab Disord (1992) 1.16
Eating behaviour in obese and normal weight 11-year-old children. Int J Obes Relat Metab Disord (1992) 1.15
A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive. Contraception (1976) 1.15
Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes. Diabetes Obes Metab (2007) 1.14
Grounding spatial language in perception: an empirical and computational investigation. J Exp Psychol Gen (2001) 1.13
Normal serum-cholesterol but low H.D.L.-cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet (1978) 1.12
Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy. Obstet Gynecol (1985) 1.12
Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol (1996) 1.11
Determination of the intravenous fat tolerance test with intralipid by nephelometry. Atherosclerosis (1972) 1.11
BioWAP, mobile Internet service for bioinformatics. Bioinformatics (2001) 1.10
Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. Obes Rev (2009) 1.10
Effect of chlorophenoxyisobutyric acid (CPIB) on fat-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat. Atherosclerosis (1973) 1.10
Effect of prostaglandin E1 on blood pressure and heart rate in the dog. Prostaglandin and related factors 48. Acta Physiol Scand (1966) 1.09
Social mapping of the obesity epidemic in Sweden. Int J Obes Relat Metab Disord (2000) 1.08
Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia. Atherosclerosis (1976) 1.08
Low A-esterase activity in serum of patients with fish-eye disease. Clin Chem (1987) 1.08
Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. Lancet (1971) 1.07
Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women. Atherosclerosis (1975) 1.06
The length of the first three menstrual cycles after combined oral contraceptive treatment. Acta Obstet Gynecol Scand (1969) 1.06
Serum lipids, intravenous glucose tolerance and their interrelation studied in ischaemic cardiovascular disease. Acta Med Scand (1966) 1.05
Disability pension, employment and obesity status: a systematic review. Obes Rev (2008) 1.05
Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat. Int J Androl (2008) 1.05
Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid. Atherosclerosis (1977) 1.05
An Internet-based weight loss programme -- a feasibility study with preliminary results from 4209 completers. Scand J Public Health (2008) 1.05
Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res (1988) 1.04
Femoral-artery infusion of prostaglandin E 1 in severe peripheral vascular disease. Lancet (1973) 1.04
Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study. J Intern Med (1990) 1.03
Liver ultrastructure and function in icteric and non-icteric women using oral contraceptive agents. Acta Med Scand (1967) 1.03
Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis (1984) 1.03
Determination of splanchnic secretion rate of plasma triglycerides and of total and splanchnic turnover of plasma free fatty acids in man. Eur J Clin Invest (1972) 1.03
Studies on burns. XII. Lipid metabolism, catecholamine excretion, basal metabolic rate, and water loss during treatment of burns with warm dry air. Acta Chir Scand (1972) 1.02
Acute effects of nicotinic acid on plasma, liver, heart and muscle lipids. Nicotinic acid in the rat. II. Acta Med Scand (1966) 1.02
Increased physical activity in abdominally obese women through support for changed commuting habits: a randomized clinical trial. Int J Obes (Lond) (2009) 1.02
Differences between capillary and venous blood glucose during oral glucose tolerance tests. Scand J Clin Lab Invest (1976) 1.02
Sexual function in obese women: impact of lower urinary tract dysfunction. Int J Obes (Lond) (2008) 1.01
Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid. Atherosclerosis (1974) 1.01
Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia. Acta Med Scand (1986) 1.01
Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high- versus low-fat content. Int J Obes (Lond) (2006) 1.01
Myocardial lipid and carbohydrate metabolism in healthy, fasting men at rest: studies during continuous infusion of 3 H-palmitate. Eur J Clin Invest (1972) 1.01
Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia. Eur J Clin Invest (1982) 1.00
Long term treatment of severe obesity: four year follow up of results of combined behavioural modification programme. Br Med J (Clin Res Ed) (1985) 1.00
Lipid metabolism and trauma. 3. Plasma lipids and lipoproteins in burns. Acta Med Scand (1965) 1.00
Mixtures of endocrine disrupting contaminants modelled on human high end exposures: an exploratory study in rats. Int J Androl (2012) 1.00
Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res (1979) 1.00
Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Horm Metab Res (1979) 1.00
Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. Diabetes Obes Metab (2007) 0.99